Scarica l'app Stockscreener
22.49
2.34%
0.4839
Precedente Chiudi:
$22.01
Aprire:
$22.49
Volume 24 ore:
1.67M
Relative Volume:
0.66
Capitalizzazione di mercato:
$2.90B
Reddito:
$642.82M
Utile/perdita netta:
$-43.54M
Rapporto P/E:
-64.34
EPS:
-0.3496
Flusso di cassa netto:
$130.12M
1 W Prestazione:
+11.51%
1M Prestazione:
+2.90%
6M Prestazione:
+73.27%
1 anno Prestazione:
+178.08%
Intervallo 1D:
$21.88
$23.15
Intervallo di 1 settimana:
$20.51
$23.15
Portata 52W:
$7.72
$26.45
10 X Genomics Inc Stock (TXG) Company Profile
Nome
10 X Genomics Inc
Settore
Industria
Telefono
(925) 401-7300
Indirizzo
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Compare TXG vs VEEV, BTSG, TEM, HQY, DOCS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
22.49 | 2.84B | 642.82M | -43.54M | 130.12M | -0.3496 |
VEEV
Veeva Systems Inc
|
169.06 | 27.94B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
52.61 | 9.98B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
53.42 | 9.70B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
83.38 | 6.98B | 1.31B | 215.20M | 408.32M | 2.4627 |
DOCS
Doximity Inc
|
25.80 | 4.76B | 637.78M | 239.40M | 307.21M | 1.1909 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-31 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2025-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2025-12-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-11 | Iniziato | Piper Sandler | Neutral |
| 2025-02-13 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | Iniziato | Leerink Partners | Outperform |
| 2024-07-22 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-07-18 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-07-10 | Downgrade | Deutsche Bank | Buy → Hold |
| 2024-06-27 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-05-01 | Downgrade | TD Cowen | Buy → Hold |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-05-10 | Iniziato | Barclays | Overweight |
| 2023-03-31 | Iniziato | Stephens | Overweight |
| 2023-02-02 | Iniziato | UBS | Neutral |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-08-18 | Downgrade | Goldman | Neutral → Sell |
| 2022-07-25 | Iniziato | Canaccord Genuity | Buy |
| 2022-07-15 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-07-15 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-09-14 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-03-15 | Iniziato | William Blair | Outperform |
| 2020-12-02 | Iniziato | Goldman | Neutral |
| 2020-09-09 | Iniziato | Morgan Stanley | Overweight |
| 2020-07-10 | Iniziato | Stifel | Buy |
| 2020-03-05 | Iniziato | Guggenheim | Buy |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-10-07 | Iniziato | BofA/Merrill | Buy |
| 2019-10-07 | Iniziato | Cowen | Outperform |
| 2019-10-07 | Iniziato | JP Morgan | Overweight |
| 2019-09-24 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
10 X Genomics Inc Borsa (TXG) Ultime notizie
MSN Money - MSN
10x Genomics (TXG) price target increased by 12.41% to 23.75 - MSN
M&T Bank Corp Has $1.19 Million Stake in 10x Genomics $TXG - MarketBeat
10x Genomics (TXG) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
10x Genomics Inc (HAM:1KJ) Dividend - GuruFocus
TXG Price Today: 10x Genomics, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
10X Genomics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
10x Genomics Inc (HAM:1KJ) Stock Price, Trades & News - GuruFocus
Q3 2025 10X Genomics Inc Earnings Call Transcript - GuruFocus
10x Genomics Inc Stock Intrinsic Values | HAM:1KJ - GuruFocus
10x Genomics Inc (HAM:1KJ) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
10x Genomics Inc Stock Warning Signs | HAM:1KJ - GuruFocus
10x Genomics Inc Stock Operating Data - GuruFocus
10x Genomics Inc (HAM:1KJ) Valuation: Fairly Valued - GuruFocus
10x Genomics Inc (HAM:1KJ) Stock Price & 30 Year Financial Data - GuruFocus
10x Genomics Inc (HAM:1KJ) Stock Earnings Transcripts - GuruFocus
10x Genomics Inc (HAM:1KJ) Competitors 2026 - GuruFocus
10x Genomics Inc (HAM:1KJ) DCF Valuation - GuruFocus
10x Genomics Inc (HAM:1KJ)Valuation Measures & Financial Statistics - GuruFocus
10x Genomics Inc (HAM:1KJ) Stock News, Headlines & Updates - GuruFocus
TXG Stock Chart | 10X GENOMICS INC-CLASS A (NASDAQ:TXG) - ChartMill
Vanguard holds 6.17M shares of 10X Genomics (NASDAQ: TXG), 5.24% stake - Stock Titan
10x Genomics investors can watch management at a May 13 BofA chat - Stock Titan
10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference - ChartMill
10x Genomics (NASDAQ:TXG) Trading Down 8%What's Next? - MarketBeat
10x Genomics joins a 100,000-patient tissue atlas across 3 continents - Stock Titan
TXG Stock Price, Quote & Chart | 10X GENOMICS INC-CLASS A (NASDAQ:TXG) - ChartMill
Vanguard Portfolio Management reports 6.98M TXG shares (NASDAQ: TXG) - Stock Titan
10x Genomics seen as key player in AI-driven biological data buildout - MSN
10x Genomics (TXG) details 2026 virtual meeting, director votes and Say on Pay - Stock Titan
Why 10x Genomics (TXG) Shares Are Trading Lower Today - Yahoo Finance
10x Genomics (TXG) Price Target Increased by 10.47% to 16.66 - MSN
TXG Financials: Income Statement, Balance Sheet & Cash Flow | 10X Genomics, Inc. - Stock Titan
10X Genomics Hits New 52-Week High at $25.69, Showcasing Market Resilience - Markets Mojo
10X Genomics Experiences Evaluation Revision Amid Strong Market Performance and Volatility - Markets Mojo
10x Genomics introduces Atera at AACR 2026 - SelectScience
10X Genomics Hits New 52-Week High of $26.44, Reflecting Strong Growth - Markets Mojo
10x Genomics (NASDAQ:TXG) Reaches New 1-Year HighHere's What Happened - MarketBeat
10x Genomics Stock Up on Atera Launch, Spatial Biology Scale Enhanced - Yahoo Finance
Bayforest Capital Ltd Has $286,000 Holdings in 10x Genomics $TXG - MarketBeat
10x Genomics (NASDAQ:TXG) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
10x Genomics (TXG) Launches Atera: A Breakthrough in Spatial Bio - GuruFocus
10x Genomics, Inc.Common Stock (NQ: TXG - The Chronicle-Journal
10 X Genomics Inc Azioni (TXG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
10 X Genomics Inc Azioni (TXG) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Saxonov Serge | Chief Executive Officer |
Mar 23 '26 |
Sale |
19.13 |
10,000 |
191,297 |
1,177,273 |
| Saxonov Serge | Chief Executive Officer |
Mar 24 '26 |
Sale |
19.52 |
5,000 |
97,612 |
1,172,273 |
| Saxonov Serge | Chief Executive Officer |
Mar 02 '26 |
Sale |
22.73 |
16,152 |
367,097 |
1,203,667 |
0.54%
2.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):